Torray FundsSuperinvestor
About Torray Funds’s 13F portfolio
Torray Funds is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Torray Funds reported $681.7M across 88 US-listed positions (). Its largest position is Royalty Pharma Plc (RPRX) at 4.5% of the reported book, and its ten biggest holdings make up 38% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 |  RPRX Royalty Pharma Plc | $58.73 −0.17% | 4.5% | 645K | $31.0M |
| 2 |  AVGO Broadcom | $383.22 +0.34% | 4.5% | 99K | $30.8M |
| 3 |  MSFT Microsoft | $389.10 +1.94% | 4.2% | 78K | $28.8M |
| 4 |  CVX Chevron Corp | $190.00 −2.46% | 4.1% | 135K | $27.9M |
| 5 |  CEG Constellation Energy | $270.00 −1.59% | 3.8% | 92K | $25.7M |
| 6 |  PSX Phillips 66 | $207.82 +0.51% | 3.8% | 141K | $25.7M |
| 7 | — Hewlett Packard Ent Ser C Conv | — — | 3.5% | 375K | $24.2M |
| 8 |  TXN Texas Instruments | $279.41 −0.06% | 3.5% | 121K | $23.5M |
| 9 |  PFE Pfizer | $24.67 +0.53% | 3.2% | 776K | $21.8M |
| 10 |  CNA CNA Financial | $54.18 +0.97% | 3.2% | 470K | $21.6M |
| 11 |  OKE ONEOK | $89.46 −3.97% | 3.2% | 239K | $21.6M |
| 12 |  PEP PepsiCo | $139.79 +2.31% | 3.1% | 136K | $21.1M |
| 13 |  ABBV Abbvie | $256.91 −0.94% | 3.0% | 94K | $20.4M |
| 14 |  KKR.PRD KKR Series D Conv 6.25 | — — | 2.8% | 481K | $19.4M |
| 15 |  AMGN Amgen | $376.26 +0.06% | 2.8% | 54K | $19.0M |
| 16 |  BX Blackstone | $132.60 +2.00% | 2.8% | 165K | $19.0M |
| 17 |  NEE NextEra Energy | $88.83 −1.06% | 2.7% | 199K | $18.5M |
| 18 |  PLD Prologis | $147.26 −0.25% | 2.6% | 133K | $17.6M |
| 19 |  MRSH Marsh | $183.31 +1.42% | 2.4% | 94K | $16.4M |
| 20 |  CMCSA Comcast Class A | $22.80 +2.24% | 2.3% | 555K | $15.9M |
| 21 |  AMZN Amazon.com | $231.39 −0.31% | 2.2% | 72K | $14.9M |
| 22 |  GOOGL Alphabet Cl A | $326.56 +2.13% | 2.0% | 46K | $13.3M |
| 23 |  AAPL Apple | $336.91 +1.17% | 1.8% | 50K | $12.6M |
| 24 |  CASY Casey's General Stores | $853.38 −0.96% | 1.8% | 17K | $12.5M |
| 25 |  JPM JPMorgan | $356.20 +0.85% | 1.7% | 39K | $11.4M |
Showing 1–25 of 88 positions on this page reported in this 13F.
Tiles are sized by portfolio weight and coloured by sector; the “est.” figure on each tile is the estimated dividend- and split-adjusted return since the first reported quarter — not the manager’s profit or cost basis.
“Est. return” = estimated dividend/split-adjusted return since the first reported quarter — not the manager’s profit or cost basis.
- Technology21%
- Healthcare19%
- Financial Services12%
- Energy11%
- Unclassified10%
- Utilities6.5%
- Consumer Cyclical5.1%
- Industrials4.8%
- Communication Services4.5%
- Consumer Defensive3.2%
- Real Estate2.6%
- Basic Materials0.5%
How this return is calculated
Estimated dividend- and split-adjusted return from the end of the first consecutive reported quarter in which the current holding appears in Bullish Whales’ 13F history, through the manager’s latest reported quarter. Current disclosed holdings only. Start dates differ by holding, changes in position size are not modeled, and positions no longer reported are excluded. Not the manager’s cost basis, purchase date, realized profit or loss, live performance, or portfolio performance.
- AddedAVGOBroadcom+9.1%$30.8M
- AddedMSFTMicrosoft+129%$28.8M
- AddedCEGConstellation Energy+383%$25.7M
- Added—Hewlett Packard Ent Ser C Conv+0.2%$24.2M
- AddedPEPPepsiCo+0.2%$21.1M
- AddedABBVAbbvie+1.0%$20.4M
- AddedKKR.PRDKKR Series D Conv 6.25+16.1%$19.4M
- AddedBXBlackstone+18.4%$19.0M
- NewCMCSAComcast Class A—$15.9M
- AddedTSMTaiwan Semiconductor+0.5%$9.2M
- ReducedRPRXRoyalty Pharma Plc−13.3%$31.0M
- ReducedCVXChevron Corp−6.5%$27.9M
- ReducedPSXPhillips 66−31.7%$25.7M
- ReducedTXNTexas Instruments−13.5%$23.5M
- ReducedPFEPfizer−3.4%$21.8M
- ReducedCNACNA Financial−4.7%$21.6M
- ReducedOKEONEOK−8.2%$21.6M
- ReducedAMGNAmgen−16.5%$19.0M
- ReducedNEENextEra Energy−15.1%$18.5M
- ReducedPLDPrologis−14.9%$17.6M
Reading Torray Funds’s 13F portfolio
Torray Funds’s $681.7M 13F book is spread across 88 reported positions and is moderately diversified, the ten largest names accounting for 38%. There are meaningful positions at the top alongside a long tail of smaller holdings. Its five largest positions are RPRX, AVGO, MSFT, CVX and CEG, led by Royalty Pharma Plc (RPRX) at 4.5% of the portfolio. The heaviest sector exposure is Technology (21%), then Healthcare (19%).
What Torray Funds changed last quarter
Between 2025-12-31 and Q1 2026, Torray Funds was a net seller: it opened 4 new positions and added to 30 more, while trimming 38 and closing 11 outright. Against a 88-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was Broadcom (AVGO), and its biggest reduction was Royalty Pharma Plc (RPRX).
What a 13F does and doesn’t reveal
A 13F captures only Torray Funds’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Torray Funds is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Torray Funds's profile on this page is built directly from those filings.
How current is the 13F data on Torray Funds's page?
It reflects Torray Funds's most recently filed 13F, currently the quarter ending Q1 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Torray Funds files its next quarterly report, this page refreshes automatically.
Can I see Torray Funds's complete list of holdings?
This page highlights Torray Funds's largest positions rather than all 88 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Torray Funds's filings.
Does a 13F show everything Torray Funds owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Torray Funds's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Torray Funds made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.